DAVITA INC. — Director's Dealing 2016

Feb 18, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2016-02-16

Reporting Person: Kogod Dennis (Pres, HCP & CEO, DVA Int.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-16	Common Stock	M	250000	$43.35	Acquired	327340	Direct
2016-02-16	Common Stock	F	173234	$62.56	Disposed	154106	Direct
2016-02-16	Common Stock	S	33290	$61.9908	Disposed	120816	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-16	Stock Appreciation Rights	$43.35	M	250000	Disposed	2016-04-13	Common Stock (250000)	Direct

Footnotes

F1: Represents the weighted average sale price of $61.9908. The range of prices for the sale of these shares was $61.94 - $62.17, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F2: The Stock Appreciation Rights were granted on 4/13/2011, of which 50% vested on 4/13/2014 and the remaining 50% vested on 4/13/2015.